Maplelane Capital’s Clarivate CLVT Stock Holding History

Maplelane Capital’s Portfolio CLVT Stock Details CLVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,125,000	Closed	-$33.4M	–	123
2020 Q4	$33.4M	Buy	1,125,000 +156,000	+16%	+$4.61M	0.42%	63
2020 Q3	$30M	Sell	969,000 -442,000	-31%	-$12M	0.55%	50
2020 Q2	$31.5M	Buy	+1,411,000	New	+$31.9M	0.59%	43

Other funds holding CLVT

LGP

Leonard Green & Partners Los Angeles, California $962M AUM 35.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Maplelane Capital's CLVT Position: Q1 2021 in Review

Maplelane Capital sold out of Clarivate (CLVT) in Q1 2021, closing a stake of 1,125,000 shares — an estimated $33.4M sold.

Maplelane Capital first reported a position in CLVT in Q2 2020 and held it in 3 quarters. The position peaked at $33.4M in Q4 2020. 189 funds tracked by Wall St. Rank hold CLVT as of Q1 2021.

Maplelane Capital reported no remaining Clarivate position as of Q1 2021 after selling out during the quarter.
Maplelane Capital sold 1,125,000 Clarivate shares in Q1 2021, an estimated $33.4M.
Maplelane Capital first reported a position in Clarivate in Q2 2020 and held it in 3 quarters.
Maplelane Capital's Clarivate position peaked at $33.4M in Q4 2020.
189 funds tracked by Wall St. Rank held Clarivate as of Q1 2021.

Based on Maplelane Capital's 13F filing for Q1 2021, filed 17 May 2021.